Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2842-2861
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2842
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2842
Table 1 Methodological framework for bibliometric analysis of gastrointestinal neoplasm risk assessment literature
Parameter | Description |
Database | Web of Science Core Collection |
Search period | 25-Oct-22 |
Search strategy | Keywords related to colorectal cancer and risk assessment, combined as (1 OR 2 OR 3) AND 4 |
Screening process | Two investigators manually screened titles, abstracts, and full texts, resulting in 1371 articles and reviews selected for analysis |
Analysis software | VOSviewer (1.6.18), CiteSpace (V6.1.R4), Bibliometrix (4.1.2) |
Analysis focus | Coauthorship, keyword cooccurrence, international collaboration, cocitation, clustering analysis, citation trends, and research topic evolution over time |
Visualization Techniques | Node size reflects citation or occurrence frequency; line connections indicate relationships; color variations represent different clusters or average occurrence years |
Table 2 The citations and output of publications worldwide
Year | Publications | Mean total citations per year | Mean total citations per article | Year | Publications | Mean total citations per year | Mean total citations per article |
2022 | 112 | 0.35 | 0.99 | 2002 | 20 | 2.38 | 47.65 |
2021 | 118 | 7.93 | 7.63 | 2001 | 15 | 3.06 | 64.33 |
2020 | 109 | 4.41 | 8.83 | 2000 | 15 | 2.3 | 50.67 |
2019 | 88 | 5.57 | 16.72 | 1999 | 17 | 1.03 | 23.65 |
2018 | 88 | 7.38 | 29.53 | 1998 | 5 | 16.62 | 398.8 |
2017 | 80 | 4.4 | 22 | 1997 | 8 | 1.84 | 46 |
2016 | 84 | 4.64 | 27.86 | 1996 | 9 | 0.92 | 24 |
2015 | 92 | 5.19 | 36.35 | 1995 | 5 | 2.4 | 64.8 |
2014 | 65 | 6.75 | 53.97 | 1994 | 5 | 2.46 | 69 |
2013 | 67 | 3.63 | 32.66 | 1993 | 4 | 1.91 | 55.5 |
2012 | 53 | 3.97 | 39.68 | 1992 | 4 | 2.92 | 87.75 |
2011 | 45 | 4 | 43.98 | 1991 | 4 | 4.51 | 139.75 |
2010 | 36 | 5.42 | 65.08 | 1990 | 0 | 0 | 121 |
2009 | 40 | 4.24 | 55.15 | 1989 | 0 | 0 | 47.65 |
2008 | 27 | 3.24 | 45.33 | 1988 | 0 | 0 | 64.33 |
2007 | 31 | 2.74 | 41.06 | 1987 | 0 | 0 | 50.67 |
2006 | 37 | 6.06 | 96.92 | 1986 | 0 | 0 | 23.65 |
2005 | 29 | 6.22 | 105.76 | 1985 | 0 | 0 | 398.8 |
2004 | 23 | 3.59 | 64.57 | 1984 | 1 | 3.18 | 46 |
2003 | 14 | 2.89 | 54.86 | NA | NA | NA | NA |
Table 3 Top 20 most common countries of authors in the research field of risk assessment for gastrointestinal neoplasms
Rank | Country | Articles | Freq | SCP | MCP | MCP_Ratio |
1 | United States | 516 | 0.38025 | 433 | 83 | 0.1609 |
2 | China | 199 | 0.14665 | 176 | 23 | 0.1156 |
3 | United Kingdom | 74 | 0.05453 | 49 | 25 | 0.3378 |
4 | Japan | 65 | 0.0479 | 57 | 8 | 0.1231 |
5 | Germany | 54 | 0.03979 | 37 | 17 | 0.3148 |
6 | Australia | 52 | 0.03832 | 26 | 26 | 0.5 |
7 | Italy | 47 | 0.03464 | 38 | 9 | 0.1915 |
8 | Netherlands | 47 | 0.03464 | 37 | 10 | 0.2128 |
9 | Canada | 34 | 0.02506 | 19 | 15 | 0.4412 |
10 | Korea | 32 | 0.02358 | 30 | 2 | 0.0625 |
11 | Spain | 18 | 0.01326 | 12 | 6 | 0.3333 |
12 | France | 17 | 0.01253 | 11 | 6 | 0.3529 |
13 | Denmark | 16 | 0.01179 | 12 | 4 | 0.25 |
14 | India | 15 | 0.01105 | 13 | 2 | 0.1333 |
15 | Sweden | 14 | 0.01032 | 13 | 1 | 0.0714 |
16 | Poland | 11 | 0.00811 | 6 | 5 | 0.4545 |
17 | Switzerland | 11 | 0.00811 | 8 | 3 | 0.2727 |
18 | Brazil | 10 | 0.00737 | 9 | 1 | 0.1 |
19 | Iran | 10 | 0.00737 | 10 | 0 | 0 |
20 | Norway | 10 | 0.00737 | 7 | 3 | 0.3 |
Table 4 Top 20 most productive institutions in the research field of risk assessment for gastrointestinal neoplasms
Rank | Institutions | Publications | Percentage of 1371 | Total link strength | Total citations | Average citation per paper |
1 | Brigham and Womens Hosp | 41 | 2.99 | 168 | 2855 | 69.63 |
2 | Nci | 39 | 2.84 | 42 | 2060 | 52.82 |
3 | Harvard Univ | 36 | 2.63 | 120 | 3721 | 103.36 |
4 | Dana Farber Canc Inst | 35 | 2.55 | 142 | 2635 | 75.29 |
5 | Univ Texas Md Anderson Canc Ctr | 30 | 2.19 | 79 | 1074 | 35.8 |
6 | Univ Melbourne | 24 | 1.75 | 81 | 759 | 31.63 |
7 | Univ Michigan | 23 | 1.68 | 92 | 1042 | 45.3 |
8 | Univ Toronto | 23 | 1.68 | 75 | 667 | 29 |
9 | Duke Univ | 22 | 1.6 | 75 | 994 | 45.18 |
10 | Mayo Clin | 22 | 1.6 | 45 | 1283 | 58.32 |
11 | Johns Hopkins Univ | 21 | 1.53 | 104 | 3262 | 155.33 |
12 | Univ Washington | 21 | 1.53 | 71 | 1372 | 65.33 |
13 | Ohio State Univ | 20 | 1.46 | 53 | 1030 | 51.5 |
14 | Columbia Univ | 19 | 1.39 | 102 | 661 | 34.79 |
15 | Mem Sloan Kettering Canc Ctr | 19 | 1.39 | 89 | 2076 | 109.26 |
16 | Natl Canc Ctr | 19 | 1.39 | 65 | 402 | 21.16 |
17 | Stanford Univ | 19 | 1.39 | 47 | 1889 | 99.42 |
18 | Univ Cambridge | 19 | 1.39 | 37 | 777 | 40.89 |
19 | Univ Utah | 19 | 1.39 | 28 | 2008 | 105.68 |
20 | Vanderbilt Univ | 19 | 1.39 | 26 | 971 | 51.11 |
Table 5 Top 20 most productive authors in the research field of risk assessment for gastrointestinal neoplasms
Rank | Author | Publications | Percentage of 1371 | Total citations | Average citation per paper |
1 | Syngal S | 24 | 1.75 | 2273 | 94.71 |
2 | Wang Y | 18 | 1.31 | 178 | 9.89 |
3 | Liu Y | 15 | 1.09 | 195 | 13 |
4 | Zhang Y | 13 | 0.95 | 145 | 11.15 |
5 | Li Y | 12 | 0.88 | 82 | 6.83 |
6 | Xu J | 12 | 0.88 | 136 | 11.33 |
7 | Orlando LA | 11 | 0.8 | 137 | 12.45 |
8 | Walter FM | 10 | 0.73 | 228 | 22.8 |
9 | Wang J | 10 | 0.73 | 52 | 5.2 |
10 | Zhang L | 10 | 0.73 | 239 | 23.9 |
11 | Emery JD | 9 | 0.66 | 160 | 17.78 |
12 | Li J | 9 | 0.66 | 245 | 27.22 |
13 | Li S | 9 | 0.66 | 240 | 26.67 |
14 | Li X | 9 | 0.66 | 130 | 14.44 |
15 | Lindor NM | 9 | 0.66 | 874 | 97.11 |
16 | Stoffel EM | 9 | 0.66 | 601 | 66.78 |
17 | Verma M | 9 | 0.66 | 379 | 42.11 |
18 | Wang X | 9 | 0.66 | 430 | 47.78 |
19 | Zhang J | 9 | 0.66 | 43 | 4.78 |
20 | Burt RW | 8 | 0.58 | 1568 | 196 |
Table 6 Top 20 most productive cocite authors in the research field of risk assessment for gastrointestinal neoplasms
Rank | Cocite author | Citations | Centrality |
1 | Lynch HT | 134 | 0.12 |
2 | Vasen HFA | 125 | 0.03 |
3 | Hampel H | 89 | 0.04 |
4 | Giardiello FM | 79 | 0.13 |
5 | Jarvinen HJ | 68 | 0.04 |
6 | Umar A | 65 | 0.05 |
7 | Siegel RL | 63 | 0.01 |
8 | Berg AO | 63 | 0.04 |
9 | Bray F | 56 | 0 |
10 | Jemal A | 55 | 0.03 |
11 | Ferlay J | 54 | 0.03 |
12 | Syngal S | 53 | 0.03 |
13 | Kastrinos F | 53 | 0.04 |
14 | Boland CR | 49 | 0.1 |
15 | Rex DK | 39 | 0.06 |
16 | Chen SN | 38 | 0.02 |
17 | Easton DF | 37 | 0.05 |
18 | Aaltonen LA | 37 | 0.17 |
19 | Lindor NM | 36 | 0.02 |
20 | Gail MH | 35 | 0.03 |
Table 7 Top 10 journals related to the research on risk assessment for gastrointestinal neoplasms
Rank | Journal | Countries | Count | IF (2021) | JCR (2021) | H-index | Total citations |
1 | Familial Cancer | Netherlands | 27 | 2.45 | Q3 | 11 | 387 |
2 | Journal of Clinical Oncology | United States | 22 | 50.717 | Q1 | 18 | 2823 |
3 | Cancer | United States | 20 | 6.92 | Q1 | 10 | 1092 |
4 | Genetics in Medicine | United States | 20 | 8.86 | Q1 | 15 | 871 |
5 | International Journal of Cancer | Switzerland | 20 | 7.32 | Q1 | 13 | 668 |
6 | BMC Cancer | England | 18 | 4.64 | Q2 | 11 | 268 |
7 | Journal of Genetic Counseling | United States | 18 | 2.717 | Q3 | 10 | 492 |
8 | Cancer Epidemiology Biomarkers & Prevention | United States | 16 | 4.09 | Q2 | 11 | 363 |
9 | Frontiers in Oncology | Switzerland | 16 | 5.738 | Q2 | 11 | 611 |
10 | Diseases of The Colon & Rectum | United States | 15 | 4.41 | Q1 | 8 | 298 |
Table 8 Top 10 cocited journals related to the research on risk assessment for gastrointestinal neoplasms
Rank | Cocited Journal | Countries | Total citations | IF (2021) | JCR (2021) |
1 | Journal of Clinical Oncology | United States | 2403 | 50.717 | Q1 |
2 | Cancer Research | United States | 1687 | 13.31 | Q1 |
3 | Gastroenterology | United States | 1669 | 33.88 | Q1 |
4 | New England Journal of Medicine | United States | 1645 | 176.079 | Q1 |
5 | International Journal of Cancer | Switzerland | 1121 | 7.32 | Q1 |
6 | Jama-Journal of The American Medical Association | United States | 1070 | 157.335 | Q1 |
7 | GUT | England | 939 | 31.79 | Q1 |
8 | Cancer Epidemiology Biomarkers & Prevention | United States | 925 | 4.09 | Q2 |
9 | British Journal of Cancer | England | 862 | 9.08 | Q1 |
10 | Lancet | England | 830 | 202.731 | Q1 |
Table 9 Top 10 cocited references concerning the research of risk assessment of gastrointestinal neoplasms
Title | First author | Journal | Year | IF (2021) | JCR (2021) | Citations |
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC | Vasen HFA | Gastroenterology | 1999 | 33.88 | Q1 | 74 |
Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability. | Umar A | Journal of The National Cancer Institute | 2004 | 11.816 | Q1 | 67 |
Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer | Jarvinen HJ | Gastroenterology | 2000 | 33.88 | Q1 | 59 |
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) | Vasen HFA | Diseases of The Colon & Rectum | 1991 | 4.41 | Q1 | 49 |
A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Bethesda Guidelines | Rodriguezbigas MA | Journal of The National Cancer Institute | 1997 | 11.816 | Q1 | 46 |
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer | Boland CR | Cancer Research | 1998 | 13.31 | Q1 | 42 |
Hereditary Colorectal Cancer | Lynch HT | New England Journal of Medicine | 2003 | 176.079 | Q1 | 42 |
Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) | Hampel H | New England Journal of Medicine | 2005 | 176.079 | Q1 | 41 |
Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually | Gail MH | Journal of The National Cancer Institute | 1989 | 11.816 | Q1 | 40 |
Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal Cancer | Hampel H | Journal of Clinical Oncology | 2008 | 50.717 | Q1 | 34 |
Table 10 The 20 most common keywords related to risk assessment for gastrointestinal neoplasms
Rank | Keywords | Total link strength | Frequency |
1 | Colorectal cancer | 417 | 200 |
2 | Risk assessment | 411 | 169 |
3 | Gastric cancer | 168 | 77 |
4 | Cancer | 167 | 70 |
5 | Lynch syndrome | 162 | 63 |
6 | Genetic testing | 136 | 49 |
7 | Colon cancer | 102 | 45 |
8 | Genetic counseling | 131 | 44 |
9 | Prognosis | 108 | 44 |
10 | Family history | 117 | 38 |
- Citation: Fu QQ, Ma L, Niu XM, Zhao HX, Ge XH, Jin H, Yu DH, Yang S. Trends and hotspots in gastrointestinal neoplasms risk assessment: A bibliometric analysis from 1984 to 2022. World J Gastrointest Oncol 2024; 16(6): 2842-2861
- URL: https://www.wjgnet.com/1948-5204/full/v16/i6/2842.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i6.2842